Boehringer Ingelheim Venture Fund — 2021 Investments
4 investments dated 2021 · listed companies and verified rows first · show all
Asgard provides sales intelligence and intent detection data to B2B companies, identifying qualified prospects and their specific needs for targeted sales outreach and account-based marketing campaigns.
AI & Machine LearningData & InfrastructureEnterprise SoftwareSales TechParis, FR
Co-investorsTechstarsIndustrifondenNovo HoldingsRobot Ventures
Asgard Therapeutics develops direct cell reprogramming technologies that convert cancer cells into dendritic cells to restore anti-cancer immune responses.
AI & Machine LearningBiotechHealthtechMedical DevicesLund, SE
Cristiana Pires(Co-founder and CEO)inFábio Rosa(Co-founder and VP of Research)inFilipe Pereira(Co-founder and Head of Innovation)in
Co-investorsIndustrifondenLU InnovationNovo Holdings
BiotechPhoenix, US
Douglas Grant McFadden, Ph.D.(Director)Steven J. Potts, Ph.D.(President and Chief Executive Officer)Ting Xiao(Director)Jason Rushton(Director)Kanad Das, Ph.D.(Director)Michael G. Wood(Executive Officer)
Co-investorsB Capital GroupCity Hill VenturesDelos CapitalKorea Investment PartnersLumira VenturesLYZZ Capital+1 more
.jpeg){kind=logo}
Optina develops a retinal imaging and AI platform for diagnosing and managing Age-Related Macular Degeneration in eye care specialists and patients.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsDigitalDx VenturesDesjardins CapitalHike VenturesZoic Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.